Previously, we showed luteal stage-specific regulation of angiogenesis-modulating factors by prostaglandin F2 alpha (PGF2alpha). Fibroblast growth factor 2 (FGF2) and thrombospondins (THBSs) exhibited the most divergent profile of induction by PGF2alpha. We therefore examined the transcriptional regulation and roles of THBSs in luteal cells and studied their interaction with FGF2. THBSs and their receptors exhibited cell-specific expression: THBS1 was the predominant form in luteal endothelial cells (LEC), whereas luteinized granulosa cells (LGC) expressed mostly THBS2. CD36 was confined to LGC, but CD47 did not exhibit preferential expression between LEC and LGC. THBS1 and THBS2 were both stimulated in vitro by PGF2a and its analog in LGC. In contrast, luteinizing signals (LH and insulin) decreased the expression of THBS1, THBS2, and CD36. Importantly, LH increased FGF2 expression, suggesting that THBSs and FGF2 are conversely regulated. We found that FGF2 inhibited THBS1 and vice versa, and that THBS1 treatment decreased FGF2 expression, suggesting reciprocal inhibition. In agreement, ablation of THBS1 by specific small interference RNAs elevated FGF2 levels. THBS1 reduced LEC numbers and promoted apoptosis by activation of caspase-3. In contrast, FGF2 reduced basal and THBS1-induced caspase-3 levels. Consistent with these findings, small interference RNA silencing of THBS1 in luteal cells reduced the levels of active caspase-3 and improved the survival of cells when challenged with staurosporine. Taken together, these studies suggest that THBSs are suppressed during luteinization but are induced by PGF2alpha in luteolysis. THBS1 has antiangiogenic, proapoptotic properties; these, together with its ability to inhibit FGF2 expression and activity, can promote luteolysis.
INTRODUCTION
The corpus luteum (CL) is a heterogeneous gland composed of steroidogenic luteal cells, endothelial cells, fibroblasts, pericytes, and immune cells [1] [2] [3] . CL development is accompanied by intense angiogenesis stimulated by two proangiogenic factors: vascular endothelial growth factor A (VEGFA) and fibroblast growth factor 2 (FGF2) [1, 4, 5] . In a nonfertile cycle, the luteolytic hormone prostaglandin F2 alpha (PGF2a) is secreted from the uterus and triggers CL regression [6, 7] . Initially, progesterone production is inhibited followed by apoptotic loss of cells within the CL [6] . However, exogenous PGF2a does not trigger regression of CL during the early stages of the cycle (Days 1-5) [8] . Using functional genomics, we recently compared PGF2a-induced gene expression profiles in PGF2a-refractory bovine CL (collected on Day 4 of the estrous cycle) versus PGF2a-responsive bovine CL (collected on Day 11) [9] . The results of the microarray analyses, validated by quantitative real-time PCR (qRT-PCR), have shown that PGF2a markedly increases the expression of the proangiogenic factor, FGF2, in the refractory CL (Day 4) but much less so in responsive CL (Day 11) [10] . In contrast, PGF2a administration on Day 11 of the cycle elevated the expression of antiangiogenic genes, including thrombospondins (THBS1 and THBS2) and their receptor, CD36 [10] . THBS1 was also augmented in sheep CL during natural luteolysis [11] . We have previously reported that THBS1 is expressed in both luteal steroidogenic and endothelial cells, and like in vivo, it was significantly induced by PGF2a in these cell types in vitro [10] . THBSs are large, secreted, multimodular glycoproteins that play complex roles in mediating cellular processes. Within the THBS family, THBS1 and THBS2 are closely related in terms of their domain organization and degree of sequence identity. Each subunit of THBS1 consists of amino-and carboxy-terminal globular domains, a region homologous with procollagen, and three types of repeated sequence motifs designated type 1, 2, and 3 repeats [12, 13] . THBS1 has been shown to inhibit angiogenesis through multiple mechanisms both in vitro and in vivo. For instance, increased vascularization occurred in the absence of THBS1 in knockout mice [14] [15] [16] . THBS1 acts via binding to specific receptors, including CD36, CD47, integrins, and proteoglycans [17] . THBS1 also combines with proangiogenic FGF2, consequently lowering its bioavailability and activity [18] [19] [20] . To gain a better understanding of the regulation and roles of THBS1 and its relationship with FGF2 in luteal cell function, we studied 1) the effects of exogenously applied THBS1 molecules or silencing of the endogenous protein by small interference RNA (siRNA), 2) the hormonal regulation of THBS1 expression, and 3) its transcriptional and functional interactions with FGF2 in luteal endothelial cells (LEC) and luteinized granulosa cells (LGC).
MATERIALS AND METHODS

Isolation and Culture of LGC
Ovaries were collected at a local slaughterhouse as previously described [21] . Only large follicles (1.2-1.5 cm in diameter) containing !4 3 10 6 cells were used. Granulosa cells were gently scraped with a glass stick and placed in Dulbecco-modified Eagle medium (DMEM)/F-12 containing 1% L-glutamine and 1% penicillin/streptomycin (Biological Industries), 10 lg/ml of DNase, hyaluronidase, and collagenase (Sigma-Aldrich). Granulosa cells were cultured in medium containing 3% fetal calf serum (FCS) (Biological Industries). After an overnight culture, the media were replaced, and the cells were incubated with DMEM/F-12 containing 1% FCS only (control), bLH (100 ng/ml; National Hormone and Peptide Program), insulin (2 lg/ml; Sigma), PGF2a (0.1 lg/ml; Cayman Chemical Co.), PGF2a analog (1 lg/ml ESTROPLAN [cloprostenol sodium]; Parnell Technologies Pty), or insulin plus bLH. After 24 h, the total RNA was isolated from cells and gene expression (THBS1, THBS2, CD36, CD47, STAR, and FGF2) was analyzed by qRT-PCR as described below.
Isolation and Culture of LEC
The procedure for LEC enrichment was described in detail before [22] . Briefly, CL were dispersed using sequential incubations with collagenase. Then cells were incubated with BS-1-coated magnetic beads. The adherent cells were washed and concentrated using a magnet until the supernatant was free of cells. BS-1-positive cells (enriched LEC fraction) were plated in DMEM/F-12 containing 10% FCS on collagen type I-coated plates (Surecoat; Advanced BioMatrix). Colonies of LEC were trypsinized with 1% crystalline trypsin (Biological Industries), collected, and reseeded; this process was repeated until homogenous cell cultures were visualized. Cell identity was verified using endothelial cell markers (CD31, EDN1), and the lack of contamination by smooth muscle cells (ACTAG2 expression) and fibroblasts (COL1A1 expression) was evaluated. Cells of passages 4-10 were utilized in this study. The LEC were seeded in 6-well dishes (100 000 cells/well) and cultured overnight in DMEM/F-12 containing 10% FCS. The next day, the cells were transferred to starvation medium (0.5% bovine serum albumin, 0.1% FCS) for 24 h and were then incubated with 5-500 ng/ml THBS1 (Genetech) or 1-15 ng/ ml FGF2 (PeproTech Asia). After 48 h, the total RNA was extracted, and gene expression was analyzed by qRT-PCR as described below.
RNA Extraction and qRT-PCR
Total RNA was isolated from cells using TriFast reagent (Peqlab Biotechnologie GmbH) according to the manufacturer's instructions. One microgram of total RNA was reverse transcripted using M-MuLV Reverse Transcriptase (200 units/ll), M-MuLV RT Buffer (New England Biolabs), random primer (100 nM), oligo-dT (100 uM), and dNTPs mix (100 mM) (Bioline Reagents Limited). Quantitative RT-PCRs were performed using the Mx3000P system (Stratagene) and Platinum SYBR Green (SuperMix; Invitrogen) as previously described [23, 24] . The glyceraldehyde 3-phosphate dehydrogenase (GPDH) gene was used as the housekeeping gene. The threshold cycle number (Ct) was used to quantify the relative abundance of the gene; arbitrary units were calculated as 2 ÀDCt ¼ 2 À(Ct target geneÀCt housekeeping gene)
. Sequences of primers used for qRT-PCR are listed in Table 1 .
Determination of Viable Cell Numbers
Cells were seeded in 96-well dishes (LEC, 3000 cells/well; LGC, 10 000 cells/well) and cultured overnight in DMEM/F-12 containing FCS (10% for LEC, 3% for LGC). The next day, the cells were transferred to starvation medium (0.5% bovine serum albumin, 0.1% FCS) for 24 h and were then incubated for 48 h with 10-1000 ng/ml THBS1 or 5-100 nM ABT-898 (Abbott Laboratories). Cell numbers were estimated as previously described in [24] using the XTT kit (Biological Industries), which measures the reduction of a tetrazolium component by the mitochondria of viable cells. On the day of measurement, XTT was added according to the manufacturer's instructions. Plates were incubated at 378C for 1-3 h. The absorbance was read at 450 nm (reference absorbance, 630 nm). LGC. Levels of mRNA were measured by qRT-PCR. Control was designated as 100%. Data are from 10 independent experiments. Data were normalized relative to the abundance of GPDH mRNA in the same samples. The results are presented as means 6 SEM. Asterisks indicate significant differences between LEC and LGC; **P , 0.01, ***P , 0.001.
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Western Blot Analyses
Proteins were extracted by adding sample buffer (32), separated by 7.5%-12.0% SDS-PAGE, and subsequently transferred to nitrocellulose membranes as we have previously reported [10, 25] . Membranes were blocked for 2 h in 20 mmol/L Tris, 150 mmol/L NaCl, and 0.1% Tween 20, pH 7.6, containing 5% low-fat milk, and then incubated overnight at 48C with rabbit anti-FGF2 antiserum (1:10 000; kindly provided by D. Schams, University of Munich), rabbit anti-caspase-3 (1:1000, ab90437; Abcam), mouse anti-THBS1 (1:500, ab1823; Abcam), or rabbit anti-p44/42 total MAPK (1:50 000; Sigma) in 1% low-fat milk. The membranes were incubated with peroxidase-conjugated goat anti-rabbit immunoglobulin G or goat anti-mouse immunoglobulin G (heavy þ light) for 1 h at room temperature. A chemiluminescent signal was generated with SuperSignal (Thermo Fisher Scientific), and the membranes were exposed. The signal was analyzed by using the Gel-Pro 32 program and normalized to total p44/42 MAPK (1:50 000; Sigma).
Transfection of Cells
Cells were trypsinized, seeded in 24-or 6-well plates, and cultured for up to 24 h. Then the cells were transfected using Lipofectamine 2000 reagent (Invitrogen) according to the manufacturer's protocol in 1% (LEC) or 3% (LGC) FCS. Cells were transfected with two siRNA sequences (GeneCust) targeting (50 nmol/L) siTHBS1_1, siTHBS1_4, or scrambled siRNA. Sequences of siTHBS1_1 were sense (S), GCCAGAACUCAGUUAC CAUdTdT, and antisense (AS), AUGGUAACUGAGUUCUGGCdTdT. Sequences of siTHBS1_4 were S, CUCAGUUACCAUCUGCAAAdTdT, and AS, UUUGCAGAUGGUAACUGAG, corresponding to bases 1169-1187 and 1176-1194, respectively, of the THBS1 mRNA sequence. Scrambled siRNA sequence-negative controls were S, UUCUCCGAACGUGUCACGUdTdT, and AS, ACGUGACACGUUCGGAGAAdTdT. Then, the total RNA or proteins were extracted from cells 48-72 h after transfection (for mRNA and protein levels, respectively). For viability experiments, LEC were transferred to starvation medium 24 h after transfection, and were treated with or without staurosporine (20-500 nM, Sigma) for 12 h the next day. Cell numbers were estimated by the XTT kit as described above.
Statistical Analyses
Data are presented as means 6 SEM; experiments were repeated at least three times. Expression of specific genes mRNA was normalized relative to the abundance of GPDH mRNA. Data were analyzed by Student t-test or one-way ANOVA. Asterisks denotes significant statistical difference from controls, *P , 0.05, **P , 0.01, ***P , 0.001. To identify the differences in gene expression between LEC and LGC ( Fig. 1) , the nonparametric Mann Whitney U test was used (SigmaPlot; Systat Software, Inc.). Asterisks represent statistical difference between cell types. **P , 0.01, ***P , 0.001.
FIG. 2. Effects of THBS1 on LEC and
LGC numbers. Serum-starved cells were incubated with control medium alone or with THBS1 (10-1000 ng/ ml; A) or ABT-898 (5-100 nM; B) for 48 h. On the day of measurement, XTT was added, and the absorbance was read at 450 nm. Data are presented as the percent of the control. Data are from four independent experiments. The results are presented as means 6 SEM. Asterisks indicate significant differences from the control; *P , 0.05, **P , 0.01, ***P , 0.001.
FIG. 3.
Effect of THBS1 on the amount of cleaved (active) caspase-3 protein level in LEC. Cells were treated for 6 h with THBS1 (50-500 ng/ml) alone (black columns) or with the addition of FGF2 10 ng/ml (white columns). Densitometric quantifications of cleaved caspase-3 determined by Western blots were normalized relative to the abundance of total MAPK (p44/42) and are shown as the percent of control. Data are from five independent experiments. The results are presented as means 6 SEM. Asterisks indicate significant differences from the control; *P , 0.05, **P , 0.01, ***P , 0.001. The # indicates significant differences between 500 ng/ml THBS1 alone and THBS1 with FGF2 (P , 0.05).
RESULTS
Luteal Cell-Specific Expression of THBSs and Their Receptors
The expression of THBSs and their receptors CD36 and CD47 were examined in both LEC and LGC (Fig. 1) . THBS1 mRNA was significantly more abundant in LEC compared with LGC (P , 0.01). In contrast, THBS2 was expressed at much higher levels in LGC than in LEC (P , 0.001). THBS2 mRNA levels were lower compared with THBS1 in both cell types. CD36 was expressed only in LGC, whereas CD47 did not exhibit preferential expression between LEC and LGC.
Effects of THBS1 on Luteal Cell Viability
To investigate the effects of THBS1 on cultured luteal cells, we used whole recombinant THBS1 protein and peptide ABT-898, which mimics properdin type I repeats of THBS1 and acts via the CD36 receptor [26] . Addition of recombinant THBS1 dramatically reduced the number of LEC (Fig. 2A) . The effect of THBS1 on LGC numbers resulted in a small decrease in their numbers (about 15%) ( Fig. 2A) . Similarly, ABT-898 peptide only moderately (about 25%) reduced the viability of LGC (Fig. 2) . In accordance with the presence of the CD36 receptor (Fig. 1) , treatment with ABT-898 did not affect the viability of LEC (Fig. 2B) . Because the treatment with THBS1 markedly reduced the number of LEC ( Fig. 2A) , we examined whether apoptotic signals were induced in these cells. Indeed, cleaved (active) caspase-3 levels were elevated by THBS1 in a dose-dependent manner (50-500 ng/ml). At 6 h after treatment with 500 ng/ml of THBS1, the levels of cleaved caspase-3 were three times higher than in the control (P , 0.05). FGF2 had an opposite effect to that exhibited by THBS1; in its presence, active caspase-3 was reduced to levels lower than those of the   FIG. 4 . THBS1, THBS2, STAR, FGF2, CD36, and CD47 mRNA abundance in LGC. Cells were placed in control medium (cont) or with bLH (100 ng/ml), insulin (Ins, 2 lg/ml), both (LHþIns), PGF2a (0.1 lg/ml), or PGF2a analog (PGana, 1 lg/ml chloprostenol) for 24 h. The mRNA levels were measured by qRT-PCR. The data shown are the percent of control. Data are from four independent experiments. The results are presented as means 6 SEM. Asterisks indicate significant differences from the control; *P , 0.05, **P , 0.01, ***P , 0.001.
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control group (P , 0.01). FGF2 was also able to partially suppress a THBS1-dependent increase in active caspase-3 (Fig.  3) .
In Vitro Regulation of THBSs and FGF2 Expression
Next, we examined the hormonal regulation of THBSs and FGF2 in LGC. As expected, bLH (100 ng/ml) with insulin and insulin on its own had a positive effect on STAR mRNA expression. Luteinization was associated with reduced levels of THBS1 and THBS2 and their CD36 receptor. On the other hand, factors inducing luteolysis-PGF2a and the PGF2a analog, cloprostenol-elevated THBS expression and the CD47 receptor. Interestingly, FGF2 was elevated by both luteinization-and luteolysis-inducing signals, but bLH had the strongest effect (Fig. 4) . Incubation of LEC for 48 h with varying doses of FGF2 (1-15 ng/ml) inhibited THBS1 mRNA levels. The most effective doses were 10 and 15 ng/ml of FGF2, which reduced THBS1 mRNA levels by approximately 60% (P , 0.05). Conversely, treatment with THBS1 (5-500 ng/ml) decreased FGF2 expression in a dose-dependent manner, with maximal inhibition reaching approximately 2-fold (Fig. 5) .
Effects of THBS1 Silencing on Luteal Cells
Because LEC and LGC both endogenously express THBS1, we studied the effects of its silencing using specific siRNA constructs. These constructs effectively reduced THBS1 mRNA by approximately 60% (P , 0.001) and protein expression by 85% (P , 0.001) in both LEC and LGC (Fig. 6, A and B) . The results indicate that silencing of THBS1 was specific and that it did not affect the expression of THBS2 (Fig. 6C) . Importantly, together with THBS1 silencing, FGF2 mRNA levels were significantly elevated, an effect observed in both cell types (Fig. 7, A and B) . In silenced LEC, FGF2 protein expression was also elevated (data not shown). The expression level of transforming growth factor beta 1 (TGFB1) was not altered in silenced LEC (Fig. 7A) . In THBS1-silenced LGC, the CD36 receptor tended to be higher (P , 0.1) whereas the expression of VEGFA did not change (Fig. 7B) . In corroboration of the data shown in Figure 3 , cleaved caspase-3 levels were significantly reduced in THBS1-silenced LEC as well as LGC compared with cells transfected with scrambled siRNA (Fig.  8) , further supporting the role of THBS1 as being proapoptotic.
Treatment of endothelial cells with staurosporine is known to induce cell death [27] [28] [29] . In accordance, LEC transfected with a negative control (scrambled siRNA) exhibited reduced cell viability when incubated with staurosporine (Fig. 9) . Importantly, however, THBS1-silenced LEC showed better survival rates. With THBS1 ablated, the number of viable cells in staurosporine doses of 20-100 nM significantly increased (Fig. 9) .
DISCUSSION
This study sheds light on the transcriptional regulation and functions of THBS molecules in luteal endothelial and granulosa cells, emphasizing the interrelationship with FGF2. A distinct, cell-specific expression pattern of the two related THBS molecules, THBS1 and THBS2, and their receptors, CD36 and CD47, was observed for luteal endothelial and granulosa cells. THBSs expression in granulosa cells was inhibited by luteinizing signals and stimulated by luteolytic factors. A reciprocal inhibition between THBS1 and FGF2 genes was noted; in accordance, ablation of THBS1 by siRNA elevated FGF2 levels. THBS1 had proapoptotic effects on LEC, whereas its silencing improved the survival of these cells. Therefore, our studies portray THBSs as antiangiogenic, proapoptotic compounds induced by PGF2a that affect the luteolytic process.
THBS1 was first identified as a natural angiogenesis inhibitor protein by Good et al. [30] . It inhibits angiogenesis by acting directly on endothelial cell migration, proliferation, survival, and apoptosis [18, [31] [32] [33] [34] . Of the five known members of the THBS gene family, only THBS1 and THBS2 contain three copies of type I repeats [35, 36] . However, although THBS1 and THBS2 share many structural features, they differ in expression patterns, localization, and some functions [35, 36] . For instance, THBS1 binds and activates latent TGFB1, whereas THBS2 binds but does not activate the latent form [37] . Nevertheless, THBS2, like THBS1, inhibits angiogenesis and tumor growth [35, 38] . These two compounds activate cellular pathways through a number of receptors such as heparan sulfate proteoglycans, integrins, CD36, CD47, and low-density lipoprotein receptor-related proteins [39] [40] [41] . 
LUTEAL CELLS' EXPRESSION AND ACTIONS OF THROMBOSPONDINS
An interesting pattern of THBSs and their receptors for ovarian cells was observed here. THBS1 is the predominant form expressed in LEC, whereas the major form in LGC is THBS2. Although we only studied the effects of THBS1, based on the known functional difference between the two THBSs, there may be distinct THBS-isoform-dependent effects in each endothelial or granulosa cell type. A major pathway by which THBS1 and THBS2 inhibit angiogenesis involves an interaction with CD36 [40, 42, 43] ; however, this receptor was only expressed in LGC. Yet rather surprisingly, the effects of THBS1 or ABT-898 type I repeats that mimic peptides that bind and activate the receptor CD36 [26] were quite modest. In contrast, treatment with recombinant THBS1 markedly reduced the number of LEC and readily promoted activation of caspase-3, leading to apoptosis, suggesting that THBS1 actions in LEC occur through a CD36-independent mechanism. A possible mechanism can be the activation of latent TGFB1 [17, 20, 44] . TGFB1, like THBS1, is induced by PGF2a in mature regressing CL [9, 45] ; furthermore, it disrupt the formation of capillarylike structures of endothelial cells of CL and can induce their death [46] . Nevertheless, whether latent TGFB1 is activated by THBS1 in LEC is yet to be explored. Unlike CD36, we found that the CD47 receptor was expressed in both LEC and LGC. The cell surface receptor CD47 is widely expressed on vascular cells and in other cell types [47] [48] [49] [50] [51] . Increased expression of CD47 has been reported to correlate with increased endothelial cell apoptosis [52, 53] . THBS1 binds CD47 in a high-affinity manner through its C-terminal domain. The THBS1-CD47 ligand receptor complex inhibits nitric oxide signaling by preventing cGMP synthesis and FIG. 6. THBS1 gene silencing. LEC (A) and LGC (B) were transfected with 50 nmol/L of scrambled siRNA (negative control; designated 100%) or specific THBS1 siRNAs (siTHBS1_1, siTHBS1_4). At 48 h posttransfection, the cells were harvested for determination of THBS1 mRNA using qRT-PCR (black columns) or after 72h for THBS1 protein using Western blot analysis (white columns and representative blot). Densitometric quantifications of THBS1 were normalized relative to the abundance of total MAPK (p44/42) and are shown as the percent change from the control (white columns). The data were from five independent experiments. Asterisks indicate significant differences from scrambled siRNA. **P , 0.01, ***P , 0.001. C) THBS2 expression in silenced and nonsilenced LEC (dark gray columns) and LGC (light gray columns). The data were from three independent experiments. FARBEROV AND MEIDAN activation; therefore, THBS1 acts as a potent inhibitor of nitric oxide-stimulated endothelial cells proliferation, adhesion, and migration [39, 54] .
In the current and previous studies, we showed that THBS1 reduced viable cell numbers and induced apoptotic cell death in LEC as evidenced by nuclear fragmentation [10] . We have now expanded these findings to show that THBS1-induced apoptosis includes activation of a caspase-3 precursor. These findings were further corroborated by data showing that THBS1-silenced luteal cells have reduced active caspase-3 levels. Examining cell response to staurosporine provided the most compelling functional evidence on the proapoptotic role of endogenous THBS1. This experiment (Fig. 9 ) demonstrated that lowering THBS1 by siRNA molecules rendered the cells more competent to withstand cell death induced by exposure to staurosporine.
The role of THBS1 in follicular function or atresia has been examined in the past using various animal models, showing a decrease in both THBS1 and CD36 expression as follicular development progresses [55] [56] [57] [58] . In contrast, THBS1 was upregulated during follicular atresia [56, 58] . Our studies provide further evidence for the role of THBS1 as a natural proapoptotic compound but also highlight the importance of THBSs to luteal function. Previously, we have shown that these compounds were specifically induced in the CL that undergoes luteolysis [10] . Zalman et al. [10] also showed that in vitro treatment with PGF2a induces THBS1 in LEC. Here we report that also in LGC, PGF2a induced THBSs expression. Our data further demonstrate that luteinizing signals such as LH and insulin (given in a superphysiological dose intended to activate IGF-1 receptors [21] ) reduce the two THBSs as well as their CD36 and CD47 receptors. These findings imply that the process of luteinization favors reduction of THBS expression and function. Conversely, these genes are elevated during luteolysis to utilize their antiangiogenic, proapoptotic abilities. Elevated PGF2a-induced THBS1 will provoke LGC death and most likely will lower their hormonal output (progesterone production)-another important hallmark of luteolysis. . Cells were treated with 50 nmol/L of scrambled siRNA (negative control; designated 100%) or THBS1 siRNAs (siTHBS1_1, siTHBS1_4). Levels of mRNA (48 h posttrasfection) were determined by qRT-PCR. The data were from five independent experiments. Asterisks indicate significant differences from scrambled siRNA. *P , 0.05, **P , 0.01, ***P , 0.001.
FIG. 8.
Caspase-3 levels in THBS1-silenced LEC (A) and LGC (B). Cells were treated with 50 nmol/L of scrambled siRNA or THBS1 siRNAs (siTHBS1_1, siTHBS1_4) for 48 h. Densitometric quantifications of cleaved caspase-3 were normalized relative to the abundance of total MAPK (p44/42) and are shown as the percent change from the control. The data were from three independent experiments. Asterisks indicate significant differences from scrambled siRNA. *P , 0.05, ***P , 0.001.
LUTEAL CELLS' EXPRESSION AND ACTIONS OF THROMBOSPONDINS
The notion of THBS1 as a negative regulator of the survival and viability of luteal cell types was also seen in its relationship with proangiogenic FGF2. FGF2 plays an essential role in inducing luteal angiogenesis. High levels of FGF2 were evident mostly during the very early luteal phase [59] and in treatment with an FGF receptor-signaling inhibitor that almost completely blocked luteal endothelial network formation [60, 61] . We previously reported that administering PGF2a to refractory, young CL robustly induced FGF2 [10] . This increase is expected to support blood vessel growth and stabilization and may play a role in the gland's ability to resist luteolysis. The evidence shown here may explain this distinct profile of FGF2 induction where LH and PGF2a are both capable of inducing FGF2 mRNA. We have previously shown that THBS1 inhibited FGF2-induced proliferation and migration of LEC [10] . This effect is most likely attained by type III repeats in a THBS1 sequence, which have been shown to sequester and inhibit FGF2 action [10, [18] [19] [20] . Additionally, FGF2 and THBS1 can functionally interact by regulating endothelial nitric oxide synthase 3 (NOS3). FGF2 is known to activate NOS3 promoter in an ERK2/1-dependent manner [62] . On the other hand, THBS1, acting via the CD47 receptor, inhibits nitric oxide/cGMP signaling [39] . The antagonistic actions of FGF2 and THBS1 were also demonstrated by the ability of THBS1 to stimulate caspase-3, whereas FGF2 inhibited its activation. FGF2 was also able to partially abrogate THBS1-induced caspase-3 activation.
Importantly, we found that THBS1 and FGF2 added exogenously to cultures of LEC mutually inhibit their expression. The knockdown of THBS1 by siRNA resulted in an increase in FGF2 mRNA in the two luteal cell types, further demonstrating that alleviation of the repression of THBS1 was necessary to induce FGF2 mRNA. The mechanisms underlying this reciprocal inhibition were not examined here. However it is plausible that FGF2 activates in LEC its well-described downstream signaling pathways that include ERK2/1 and the PI-3 kinase-AKT pathway [18, 63] . THBS1 can signal through the CD47-induced signal-regulatory protein-a that controls cell responses through recruitment and phosphorylation of Src homology domain 2-containing phosphatase-1 [64] . Moreover, it was shown recently that THBS1 suppresses c-Myc expression, which is now recognized to be a universal amplifier of the expression of actively transcribed genes [50] . However, the specific cascades that mediate in the reciprocal inhibition by THBS1 and FGF2 in LEC are unknown and need further research. Taken together, our previous study [10] and the current one show that THBS1 inhibits FGF2 at several levels: 1) transcriptionally and 2) functionally, that is, the ability to promote cell proliferation, migration, and survival.
Most reports, especially those dealing with cancer biology, emphasize the interaction between THBS1 and VEGFA [65] [66] [67] ; however, in luteal cells, we could not detect any direct transcriptional regulation between THBS1 and VEGFA (Fig.  7B) as found here for FGF2. Whether these results represent fundamental differences in the regulation of CL and malignant tissues is worth further research. Taken together, the findings reported here suggest that the proapoptotic properties of THBS1, coupled with its ability to inhibit FGF2 expression and activity, may prove to be critical for luteal regression. The change in viable cell numbers (as the percentage of control) is presented. The data were from three independent experiments. Asterisks indicate significant differences from scrambled siRNA. *P , 0.05, **P , 0.01.
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